Nuclear Medicine
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Nuclear medicine study from skull base to mid-thigh with ct scan | 145,569 |
| Dxa bone density measurement of hip, pelvis, spine | 93,368 |
| Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 69,339 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 65,269 |
| X-ray of chest, 1 view | 62,643 |
| Established patient office or other outpatient visit, 30-39 minutes | 58,884 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 45,371 |
| Piflufolastat f-18, diagnostic, 1 millicurie | 44,469 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 40,226 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 35,054 |
| Nuclear medicine study of bone and/or joint whole body | 31,047 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30,340 |
| Nuclear medicine study whole body with ct scan | 26,916 |
| X-ray of chest, 2 views | 23,019 |
| Ct scan of abdomen and pelvis with contrast | 22,658 |
| Ct scan of chest with contrast | 18,534 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18,330 |
| Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 17,946 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17,755 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 13,441 |
| Screening mammography | 13,158 |
| Screening 3d breast mammography | 12,731 |
| Ct scan head or brain without contrast | 12,268 |
| Ct scan of chest without contrast | 12,229 |
| Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 10,694 |
| Nuclear medicine study of lung ventilation and circulation | 9,722 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 9,389 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 9,349 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 9,329 |
| Ct scan of abdomen and pelvis without contrast | 8,752 |
| Nuclear medicine study of heart muscle blood flow by pet | 8,549 |
| X-ray of abdomen, 1 view | 7,838 |
| Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 7,624 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 7,498 |
| Injection of additional new drug or substance into vein | 7,430 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 7,210 |
| Nuclear medicine study of stomach to assess emptying | 7,054 |
| Established patient office or other outpatient visit, 20-29 minutes | 7,036 |
| Established patient office or other outpatient visit, 40-54 minutes | 6,752 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 6,182 |
| New patient office or other outpatient visit, 45-59 minutes | 6,053 |
| Complete ultrasound scan behind abdominal cavity | 5,823 |
| Telephone medical discussion with physician, 11-20 minutes | 5,631 |
| Interpretation of trabecular bone score (tbs) and report on fracture risk | 5,529 |
| Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 5,520 |
| Radioactive drug therapy through a vein | 5,331 |
| Ct scan of blood vessels of chest with contrast | 4,877 |
| Nuclear medicine study of liver and bile duct system | 4,681 |
| X-ray of hip, 2-3 views | 4,654 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 4,581 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 4,555 |
| Ultrasound of both sides of head and neck blood flow | 4,474 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 4,397 |
| Nuclear medicine study of lung circulation | 4,299 |
| X-ray of shoulder, minimum of 2 views | 4,072 |
| Nuclear medicine study of lymphatic system | 3,939 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 3,736 |
| Complete ultrasound scan of abdomen | 3,735 |
| Dxa bone density measurement of forearm, finger, hand, or foot | 3,653 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 3,465 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 3,461 |
| Ct scan of upper spine without contrast | 3,388 |
| Telephone medical discussion with physician, 5-10 minutes | 3,359 |
| Nuclear medicine study of bone taken at different times | 3,295 |
| Limited ultrasound scan of abdomen | 3,291 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 3,255 |
| X-ray of foot, minimum of 3 views | 3,158 |
| X-ray of knee, 1-2 views | 2,982 |
| Injection of drug or substance into vein | 2,849 |
| X-ray of lower and sacral spine, 2-3 views | 2,784 |
| Nuclear medicine study of brain with metabolic evaluation | 2,779 |
| X-ray of knee, 3 views | 2,670 |
| Heart muscle strain imaging | 2,591 |
| Nuclear medicine study of kidney, blood, flow, and function with drug administration | 2,520 |
| Blood glucose (sugar) level | 2,467 |
| X-ray of knee, 4 or more views | 2,436 |
| Ultrasound scan of head and neck soft tissue | 2,402 |
| Mri scan of lower spinal canal without contrast | 2,370 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 2,283 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 2,275 |
| Aspiration and/or injection of fluid from large joint | 2,262 |
| Nuclear medicine study of heart muscle at rest and with stress and spect | 2,253 |
| Nuclear medicine study of parathyroid with spect and ct scan | 2,242 |
| Low dose ct scan of chest for lung cancer screening | 2,215 |
| Removal of skin and tissue, 20.0 sq cm or less | 2,136 |
| Ct scan of abdomen and pelvis before and after contrast | 2,017 |
| Mri scan of brain before and after contrast | 2,001 |
| Fluoroscopic guidance for needle placement | 2,000 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 1,957 |
| Ultrasound of heart, follow-up | 1,940 |
| Mri scan of brain without contrast | 1,924 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 1,923 |
| Imaging for evaluation of swallowing function | 1,912 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 1,881 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 1,832 |
| Insertion of needle into vein for collection of blood sample | 1,811 |
| Ultrasound of heart with probe in esophagus, with report | 1,783 |
| Diagnostic mammography of 1 breast | 1,670 |
| Blood test, clotting time | 1,667 |
| X-ray of hand, minimum of 3 views | 1,658 |
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).